Population Pharmacokinetic Analysis of Didanosine (2′,3′-Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS-Related Complex (Q58416812)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Population Pharmacokinetic Analysis of Didanosine (2′,3′-Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS-Related Complex	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complex (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

phase I clinical trial

1 reference

based on heuristic

inferred from title

AIDS-related complex

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

author name string

S M Pai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

U A Shukla

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

T H Grasela

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

C A Knupp

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

R Dolin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

C McLaren

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

H A Liebman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

R R Martin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

K A Pittman

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 March 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

242-247

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Population pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Population pharmacokinetics of racemic warfarin in adult patients

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Forecasting individual pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1992.TB03832.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1992.TB03832.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1564128%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58416812&oldid=2143328246"